Literature DB >> 4905242

Drug treatment in depressive illness.

K Rickels, P E Gordon, B W Jenkins, M Perloff, T Sachs, W Stepansky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4905242

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN： 0012-3714


× No keyword cloud information.
  9 in total

1.  Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice.

Authors:  J A Hollyman; P Freeling; E S Paykel; A Bhat; P Sedgwick
Journal:  J R Coll Gen Pract       Date:  1988-09

2.  Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

3.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

4.  A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness.

Authors:  J P Feighner; B Brauzer; A J Gelenberg; E Gomez; A Kiev; M L Kurland; B L Weiss
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

5.  Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care.

Authors:  L M Mynors-Wallis; D H Gath; A R Lloyd-Thomas; D Tomlinson
Journal:  BMJ       Date:  1995-02-18

Review 6.  Low dosage tricyclic antidepressants for depression.

Authors:  T Furukawa; H McGuire; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2003

7.  Controlled trial of amitriptyline in general practice.

Authors:  T G Blashki; R Mowbray; B Davies
Journal:  Br Med J       Date:  1971-01-16

8.  Antidepressants plus benzodiazepines for adults with major depression.

Authors:  Yusuke Ogawa; Nozomi Takeshima; Yu Hayasaka; Aran Tajika; Norio Watanabe; David Streiner; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

9.  Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival.

Authors:  Michael Dietachmayr; Abirami Rathakrishnan; Oleksandra Karpiuk; Felix von Zweydorf; Thomas Engleitner; Vanesa Fernández-Sáiz; Petra Schenk; Marius Ueffing; Roland Rad; Martin Eilers; Christian Johannes Gloeckner; Katharina Clemm von Hohenberg; Florian Bassermann
Journal:  Nat Commun       Date:  2020-03-09       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.